We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

47 hedge funds and large institutions have $231M invested in Minerva Neurosciences in 2026 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 3

114% more capital invested

Capital invested by funds: $108M → $231M (+$123M)

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

42% more funds holding

Funds holding: 33 → 47 (+14)

35.18% more ownership

Funds ownership: 53.32% → 88.5% (+35%)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

Holders
47
Holders Change
+14
Holders Change %
+42.42%
% of All Funds
0.58%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.02%
New
18
Increased
8
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$24.6M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$24.4M
3
FCMV
Foresite Capital Management VI
California
+$11.4M
4
TECP
Trails Edge Capital Partners
Georgia
+$8.14M
5
DT
DV Trading
Illinois
+$5.1M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$8.14M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$1.48M
3
LGM
Logos Global Management
California
-$551K
4
Renaissance Technologies
Renaissance Technologies
New York
-$341K
5
LPC
Lion Point Capital
New York
-$141K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
26
Apella Capital
Connecticut
$284K -$746 -130 -0.3%
BFA
27
Brendel Financial Advisors
New Hampshire
$252K +$240K +41,799 New
Bank of America
28
Bank of America
North Carolina
$241K +$229K +39,919 +78,273%
Goldman Sachs
29
Goldman Sachs
New York
$193K +$184K +32,012 New
Charles Schwab
30
Charles Schwab
California
$187K +$178K +31,000 New
BHCM
31
Brevan Howard Capital Management
Jersey
$172K +$164K +28,629 New
Morgan Stanley
32
Morgan Stanley
New York
$147K +$76.2K +13,277 +120%
VGA
33
Vanguard Global Advisers
Pennsylvania
$144K +$137K +23,853 New
Two Sigma Investments
34
Two Sigma Investments
New York
$129K -$5.16K -900 -4%
CGIM
35
Cannon Global Investment Management
Florida
$107K +$102K +17,758 New
OAC
36
OMERS Administration Corp
Ontario, Canada
$62.1K +$59.1K +10,300 New
Acadian Asset Management
37
Acadian Asset Management
Massachusetts
$28K -$33.3K -5,812 -55%
Carson Wealth (CWM LLC)
38
Carson Wealth (CWM LLC)
Nebraska
$2.53K – – –
LFG
39
Larson Financial Group
Missouri
$2.41K – – –
FFO
40
Fortitude Family Office
Arizona
$1.83K – – –
SS
41
SBI Securities
Japan
$1.51K – – –
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$1K -$12.3K -2,148 -96%
Barclays
43
Barclays
United Kingdom
$880 +$838 +146 New
Northwestern Mutual Wealth Management
44
Northwestern Mutual Wealth Management
Wisconsin
$602 – – –
FFA
45
Farther Finance Advisors
California
$560 – – –
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$374 – – –
AIM
47
Anchor Investment Management
South Carolina
$72 – – –
LPC
48
Lion Point Capital
New York
– -$141K -35,000 Closed
Deutsche Bank
49
Deutsche Bank
Germany
– -$6.03K -1,500 Closed
TRCT
50
Tower Research Capital (TRC)
New York
– -$2.01K -501 Closed
1
2

NERV Hedge Fund Activity: Q1 2026 in Review

47 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q1 2026, worth a combined $231M — up 114% from $108M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new NERV positions and 3 closed out — a net gain of 15 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $24.6M. The largest seller was Adage Capital Partners, cutting an estimated $8.14M.

  • 47 institutional investors held Minerva Neurosciences (NERV) as of Q1 2026, up from 33 in Q4 2025.
  • Funds reported $231M of Minerva Neurosciences stock for Q1 2026, up 114% quarter-over-quarter.
  • 18 funds opened new Minerva Neurosciences positions in Q1 2026 and 3 closed out, a net change of +15 holders.
  • The largest Minerva Neurosciences buyer in Q1 2026 was Janus Henderson Group, an estimated $24.6M added.
  • The largest Minerva Neurosciences seller in Q1 2026 was Adage Capital Partners, an estimated $8.14M sold.

Based on aggregated 13F filings for Q1 2026.